Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO)
Brief Summary:
The goal of this clinical research study is to learn if giving durvalumab alone or in combination with tremelimumab to patients with oropharynx carcinoma before standard-of-care surgery can help to control the disease.
The safety of these drugs will also be studied.